通过人工智能和基于相互作用的建模,揭示炎症性肠病中的代谢物-微生物群相互作用
Rebecca Hodgkiss1, Animesh Acharjee2
1College of Medicine and Health, Cancer and Genomic Sciences, University of Birmingham, B15 2TT Birmingham, UK.
Biochimica et biophysica acta. Molecular basis of disease
|December 11, 2024
概括
这项研究揭示了炎症性肠道疾病 (IBD) 中不同的肠道微生物组和代谢组概况. 确定了关键的微生物家族和代谢途径,为IBD提供了潜在的新诊断和治疗点.
科学领域:
- 胃肠道学和微生物组研究
背景情况:
- 炎症性肠病 (IBD) 影响全球数以百万计的人,对其病理学和原因的理解有限.
- 肠道微生物组失调和改变的新陈代谢与IBD风险因素如免疫力下降和饮食密切相关.
研究的目的:
- 识别与IBD相关的特定微生物和代谢特征.
- 探索肠道微生物组和代谢组在IBD病变发生过程中的相互作用.
- 发现IBD潜在的非侵入性诊断标志物和治疗点.
主要方法:
- 使用液态染色体质谱法 (LC-MS) 来分析220个便样本的基因组学和代谢学数据.
- 统计分析 (Wilcoxon测试) 和机器学习模型 (随机森林,XGBoost,LASSO) 用于特征选择.
- 验证人类微生物组项目2 (HMP2) 数据集和微生物社区建模 (MICOM) 进行相互作用预测.
主要成果:
- 在多个模型中确定了Flavronifractor属和Lachnospiraceae/Oscillospiraceae家族的不同丰度.
- 关键的代谢途径包括CoA生物合成,胆酸代谢和氨基酸代谢.
- 在IBD患者中突出了明确的相互作用微生物组和代谢组配置文件.
结论:
- 该研究确定了IBD特征的特定微生物和代谢特征.
- 这些发现表明炎症性肠病的潜在新型治疗点和非侵入性诊断方法.
- 对这些交互途径进行进一步的研究是IBD管理的必要条件.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
9.5K
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
112
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
112
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
316
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
316
Irritable Bowel Syndrome I: Introduction
246
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
246
